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We report a child with Hermansky-Pudlak Syndrome (HPS) and chronic kidney disease (stage II) with histological diagnosis
of focal segmental glomerulosclerosis (FSGS). A 15-year-old male of Puerto Rico ancestry with history of HPS, hypertension
(HTN), asthma, obesity, and chronic kidney disease (CKD) stage II presented with new-onset proteinuria without edema. His
blood pressure had been controlled, serum creatinine had been 0.9–1.4mg/dL, and ﬁrst morning urine protein/creatinine ratio
(UPC) ranged from 0.2 to 0.38. Due to persistent nonorthostatic proteinuria with CKD, renal biopsy was performed and FSGS
(not otherwise speciﬁed) with chronic diﬀuse tubulopathy (tubular cytoplasmic droplets) and acute tubular injury was reported.
Ceroid-like material is known to inﬁltrate tissues (i.e., lungs, colon, and kidney) in HPS, but the reason for the renal insuﬃciency
is unknown. Nonspeciﬁc kidney disease and in one adult case IgA nephropathy with ANCA-positive glomerulonephritis have
previously been reported in patients with Hermansky-Pudlak syndrome. To our knowledge, we report the ﬁrst pediatric renal
pathology case of HPS associated with CKD. This paper discusses presentation and management of renal disease in HPS.
1.Introduction
Hermansky and Pudlak reported in 1959 two cases of unre-
lated albinos with lifelong bleeding tendency and peculiar
pigmented reticular cells in the bone marrow as well as in
lymph nodes and liver biopsies. One albino was female and
the other was male, both were 33 years old. The female
had renal insuﬃciency. After her death, autopsy revealed
horseshoe kidney with large amount of pigment in reticu-
loendothelial cells and in the walls of small blood vessels
[1]. Hermansky-Pudlak syndrome (HPS) is an autosomal
recessive disorder that is caused by diﬀerent genetic muta-
tions [2]. This syndrome is characterized by oculocutaneous
albinism, platelets storage-pool deﬁciency, and lysosomal
accumulation of ceroid lipofuscin [2]. These patients have
decreased skin and hair pigmentation and transillumination
of the iris with markedly decreased visual acuity. Patients
with HPS have easy bruisability, secondary to the absence of
platelet dense bodies, which trigger platelet aggregation [2].
Ceroid lipofuscin is an amorphous lipid protein complex,
and its accumulation in tissues is believed to be responsible
for pulmonary ﬁbrosis and granulomatous colitis [3]. This
ceroid lipofuscin also accumulates in the kidney, giving it
a dark appearance when examined during an autopsy or
kidney biopsy [4, 5]. Although no speciﬁc renal disease has
beenattributedtoHPS,compromisedrenalfunctioninthese
patients has been reported [1, 4]. Renal insuﬃciency has
beenthoughttooccurduetotheceroidlipofuscindeposition
in the kidney. Gahl et al. reported a series of 49 patients with
HSP,ofwhich9hadCKD;however,nokidneybiopsieswhere
performedand there is no information about the proteinuria
and hypertension in any of the above reports [2].
To our knowledge, we report the ﬁrst pediatric renal pa-
thology caseof HPSassociatedwithCKD, tubularpathology,2 International Journal of Nephrology
focal segmental glomerulosclerosis (FSGS), and hyperten-
sion.
2.CaseReport
The patient is a 15-year-old male born in Puerto Rico to
nonconsanguineous parents of Puerto Rican descent. He
moved to the USA when he was 2 years old at which time
the diagnosis of HPS was made by hematologist who saw
him because of easy bruisability and prolonged bleeding
time. Genetic testing was done, and he was found to be
homozygous for the 16bp duplication in the HPS1 gene,
which is denoted c.1472 87dup 16 on the cDNA level. The
3.9kb deletion in the HPS3 gene was not present. He had
no known family history in parents, grandparents, and
immediaterelativesofrenalfailure,albinism,orknownHPS,
although paternal grandmother had hypertension.
Our service was consulted secondary to persistent hyper-
tension detected during a hospitalization for asthma-like
symptoms, when he was 8 years old. He had no history of
obstructive sleep apnea with negative sleep study. Physical
examination at that time showed an active child, with global
developmental delay, albino, obese (with body mass index
>95th for age) with normal cardiovascular and respiratory
exam. He had horizontal nystagmus; rest of neurological
exam was within normal limits. He had no fever, heart
rate was 96 beats per minute, and blood pressure in the
right arm was 149/93mmHg, left arm 127/78mmHg, right
leg 154/64mmHg, and left leg 151/77mmHg in sitting
position. Serum chemistries showed sodium of 135mg/dL,
potassium of 3.8mg/dL, blood urea nitrogen of 16mg/dL,
and creatinine of 1mg/dL. Urine analysis showed no protein
or blood at that time. Echocardiogram (ECHO) showed
mild left ventricular hypertrophy (LVH). Renal ultrasound
showed both kidneys to be normal in position and without
evidence of hydronephrosis. The right kidney measured
8.4cm, and left kidney measured 9.7cm. Doppler exami-
nation demonstrated patency of renal veins, with resistance
indices 0.5 (right renal artery) and 0.6 (left renal artery).
His hypertension workup included normal serum/urine
catecholamines, thyroid function tests, and normal brain
imaging (MRI head). To control hypertension, a long-acting
calcium channel blocker was started. Since then, patient’s
bloodpressurewas<90percentileforage,gender,andheight.
LVH subsequently resolved as documented on follow-up
ECHO at age of 9 years.
At 12 years of age, calcium channel blocker was stopped,
secondary to gingival hyperplasia, and an angiotensin recep-
tor blocker (ARB) was started. At that time, patient did not
have proteinuria. His blood pressure continued to be well
controlled while on ARB. His serum creatinine remained
stable (ranged from 1 to 1.3mg/dL), and serum potassium
ranged from 3.8 to 4.6mg/dL. In this time period, his BMI
increased from 31 to 34. Due to chronic abdominal pain,
he had a gastric, duodenum, and colonic biopsies done,
which showed mild acute-chronic inﬂammation (there were
no bleeding complications).
During his routine follow-up visit at age 14 years,
30mg/dL of protein without hematuria was noted on the
dipstix, but measured urine protein/creatinine ratio (UPC)
of this sample was 0.2. He was seen in the renal clinic every
3–6 months, and since then his ﬁrst morning UPC ranged
from 0.2 to 0.38. A reliable 24-hour urine collection was not
possible to obtain due to his developmental delay.
When he was 15 years old, his blood pressure was still
controlled with ARB, his serum creatinine was elevated at
1.4mg/dL,andproteinuriabecameﬁxed,thatis,1stmorning
UPC was 0.38 and 0.5. First morning urinalysis showed pH
of 6, yellow color, speciﬁc gravity 1.020, 100mg/dL protein,
no blood, and no glucose, and microscopic examination
showed 0–3 red blood cells per high-power ﬁeld and 0–5
white blood cells per high-power ﬁeld, without casts, indic-
ative of functional renal concentrating and acidifying abil-
ities. He had no edema and no hematuria, and his serum
albumin was 4.2g/dL. Total cholesterol was 138mg/dL.
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lupus; complement 3 and 4, antinuclear antibodies, and
vasculitis; antineutrophil cytoplasmic antibodies (ANCA)
were all negative. Kidney biopsy was performed due to
persistentproteinuriaandcompromisedrenalfunction,with
estimated GFR 70mL/min/1.73m2 by Schwartz formula
[6]. The hematology service was consulted prior to biopsy
and coagulation studies: prothrombin time (PT) was 10.5
seconds(normal9.5–12seconds)andpartialthromboplastin
time was 26.9 seconds (normal 26.2–33.8 seconds). Immedi-
ately after the kidney biopsy, a small perinephric hematoma
was observed by ultrasonographic evaluation but no gross
hematuria was seen and there were no other complications
during and after the procedure. Patient went home the same
day.
3.Pathology
On gross pathologic examination, kidney tissue was dark
brown. Tissue for light microscopy was evaluated at 10
section levels with H&E, PAS, and trichrome staining. There
were total 19 glomeruli in two renal biopsy cores of tan-red
cylindrical tissue each core up to 1.2cm and 1.9cm. There
were three sclerotic glomeruli, including one with segmental
hyalinosis; one of the four additional enlarged glomeruli
per level of section had perihilar segmental sclerosis. No
glomerular hypercellularity, no necrosis, and no crescents
werepresent.Mildinterstitialﬁbrosiswithassociatedtubular
atrophy, and no signiﬁcant interstitial inﬂammation was
present. Acute tubular injury with variable tubular ectasia,
variable hypertrophic tubular epithelial cells with marked
cytoplasmic vacuolization, fuchsinophilic and PAS-negative
waxy dull brown-yellow spherule cytoplasmic inclusions
werepresent.Tubularepithelialsimpliﬁcationandindividual
cell dropout with luminal granular casts were present.
Injuredtubuleshadscatterednucleiwithmarginatednuclear
chromatin and central clearing. No arteriosclerosis was
present, and no vascular inﬂammatory lesions were present,
Figures 1(a)–1(c). On immunoﬂuorescent examination, up
to 3 enlarged glomeruli per level of section had irregular
coarse granular capillary wall and mesangial staining with
antisera speciﬁc for C3. The glomeruli had no staining with
antisera speciﬁc for IgG, IgA, IgM, C1q, kappa light chains,International Journal of Nephrology 3
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Figure 1: (a) Perihilar segmental sclerosis (PAS, original magniﬁcation 20x). (b) Diﬀuse tubulopathy: variably size tubular proﬁles,
hypertrophic tubular epithelial cells, cytoplasmic vacuolization, and coarse fuchsinophilic cytoplasmic accumulations (trichrome, original
magniﬁcation20x).(c)Diﬀusetubulopathy:tubularepithelialcellcytoplasmicirregularwaxybrown-yellowceroid-lipofuscin—likepigment
accumulations (black arrow) (PAS, original magniﬁcation 40x).
or lambda light chains. No signiﬁcant extraglomerular stain-
ing was present. Diﬀuse tubular cytoplasmic droplets were
present. Oil red O stain was negative for tubular lipid.
Electron microscopy (Figure 2) revealed no capillary wall
ormesangialimmunecomplex-typeelectron-densedeposits.
Infrequent, visceral epithelial foot process eﬀacement was
present.Noendothelialtubuloreticularinclusionswereiden-
tiﬁed.
4. Discussion
Although original description of HPS originated in Prague,
the majority of literature reports describing this syndrome
have come from Puerto Rico [2]. When Hermansky and
Pudlak reported for the ﬁrst time in 1959 [1] two cases of
albinism and prolonged bleeding time, renal insuﬃciency
was described in one patient with horseshoe kidney. Tagboto
et al. [4]r e p o r t e dap a t i e n tw i t hH P Sw i t hI g An e p h r o p a t h y
and ANCA-positive glomerulonephritis. The kidney tissue
showed a dark-brown pigmentation, and the tubular injury
was similar to what we found in our case. Ceroid-like
lipofuscin material has been found in the urine of HPS
patients with renal involvement [7], and the deposition of
this material in other tissues (lungs, colon) has been blamed
for cellular dysfunction and subsequently ﬁbrosis, although,
Figure 2: Fenestrated endothelium, intact glomerular basement
membranes, and infrequent podocyte foot process eﬀacement
(transmission electron microscopy, original magniﬁcation 6000x).
if this is the cause, the exact mechanism has not been
described. The mechanism of injury of renal tubular cells by
lipofuscin accumulation is not completely understood.
HPS is a rare, autosomal recessive disorder which aﬀects
multiple cytoplasmic organelles: melanosomes, platelet4 International Journal of Nephrology
dense granules, and lysosomes. HPS can be caused by muta-
tion in several genes: HPS1 (common among population of
the Northwestern part of Puerto Rico) [8], HPS3 [9], HPS4
[10], HPS5 [11], and HPS6 [12]. HPS2 [13], which includes
immunodeﬁciency in its phenotype, is caused by a mutation
in the AP3B1 gene [14]. HPS7 is caused by a mutation in
the DTNBP1 gene [15]. HPS8 is caused by a mutation in
the BLOC1S3 gene [16]. HPS is characterized by defect in
the coat-protein complexes resulting in abnormal function
of lysosomes, melanosomes, and platelet dense granules as
HPS-gene products are part of distinct protein complexes:
the adaptor complex AP-3 and various BLOCs (biogenesis
of lysosome-related organelles complex) [14–16]. Although
there is no data to support it, it is plausible to hypothesize
that podocytes of HPS subjects may demonstrate molecular
defects in proteins analogous to dysbindin (part of BLOC-1,
found in axonal synapses) involved in lysosomal traﬃcking.
The HPS phenotype is heterogenic, and it was reported
that HPS observed in an isolated Swiss Alps village [17, 18]
usually shows a relatively mild clinical course with normal
life expectancy and the lack of clinical manifestations of
ceroid storage. Our patient presents yet another phenotype
with HTN and constellation of renal lesions that include
evidence of tubular injury and FSGS.
Patients with HPS have mild prolonged bleeding time
secondary to functionally impaired platelets, but platelet
numbers are normal. Our patient had had a gastric and
colonic biopsy in the past, as well as a tooth removal
withoutsigniﬁcantbleeding.Wehadnotobservedsigniﬁcant
complications during and after the kidney biopsy. Slow rise
in serum creatinine from 1mg/dL at age 8y to 1.4mg/dL at
age16ymightbeclinicallyimportantinourcasedescription,
indicative of slow progression despite multiple risk factors:
obesity, HTN, FSGS, and presence of tubular fuchsinophilic
cytoplasmic inclusions with mild interstitial ﬁbrosis on renal
biopsy.
To the best of our knowledge, there are no previous
reports of pediatric HPS patients with described renal
pathology. The animal model of HPS is the Fawn-Hooded
rat (FH) and pale ear mouse [19, 20]. The FH rat has an
inherited platelet storage-pool deﬁciency and a widespread
impairment of serotonin storage, susceptibility to systemic
and pulmonary hypertension, but does not have mutations
in the gene homologous to HPS1. The FH rat has a genetic
predisposition to develop chronic renal failure, FSGS, HTN,
and proteinuria [19]. The progression of sclerosis results
in premature death from end-stage kidney disease in these
rats. But the precise cause of the spontaneous development
of systemic hypertension in FH rats is not well understood
[19]. HPS1 is homologous with the “pale ear” mouse (ep
mutation). In that mouse, there is lysosomal accumulation
of beta-galactosidase and EM showed large multilamellar
granules in proximal tubules with the accumulation of
lipofuscin material in the tubules [20].
In the last decade, there has been an increased incidence
of FSGSassociated withobesity [21].Verani [22]r e po rt ed1 4
biopsies of obese adults with FSGS. In that report, glomeru-
lomegaly was reported in patients with FSGS associated
with obesity, as well as lack or hyperplasia of glomerular
epithelial cells. In that report, patients with FSGS associated
with obesity had higher cholesterol and atherosclerosis. Our
patient had normal cholesterol and no atherosclerosis on
biopsy. Kambham et al. reported that only 10% of their
patients with idiopathic FSGS had glomerulomegaly [21].
No tubular lesions, as in the case of our patient, had been
reported in FSGS associated with obesity. In a previous
case of HPS, tubular atrophy and accumulation of a ceroid-
like material in tubular epithelial cells were reported [4].
Obesity has not been a part of phenotypic description of
HPS. Our patient had increased BMI and hypertension with
LVHsinceinitialpresentationatage8years.Wecanspeculate
that HTN was secondary to obesity at 8 years of age but
it would be uncommon clinical scenario to encounter the
child at this age with HTN signiﬁcant enough to cause
LVH due to obesity alone. He had no history of obstructive
sleep apnea. Our patient did not have evidence of renal
artery stenosis or endocrine causes of hypertension, and
his blood pressure was controlled with monotherapy. The
eﬀects on the kidney secondary to obesity in animals and
humans include structural and functional changes, such
as increased GFR, increased renal blood ﬂow, and renal
hypertrophy [21, 22]. Some of the changes in the renal tissue
of our patient might be consistent with FSGS associated with
obesity, and the tubular changes may contribute to the renal
insuﬃciency. Although it is not our intention to draw any
association between HPS and FSGS, we can speculate that
obese patients with HPS and hypertension may be at risk of
unrecognized FSGS. However, it is possible that the sclerosis
of the glomeruli observed in our case is secondary to the
tubular damage.
To the best of our knowledge, this is the ﬁrst pediatric
case of HPS associated with CKD and deﬁned renal pathol-
ogy. Further studies are needed to determine the cause of
renal insuﬃciency in patients with HPS.
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